[ad_1]
White House Chief of Staff Mark Meadows asked the head of the US Food and Drug Administration, Steven Hahn, to approve the Pfizer vaccine; otherwise, he prepared for his resignation.
RELEVANT ARTICLES
According to Reuters, the White House is pressing the FDA for immediate decisions to continue the coronavirus vaccination program as soon as possible. Meadows and Khan called Friday to discuss the matter. We remind you that sources in the United States assured that the vaccine would be approved even today, something that has not yet been confirmed.
Speaking to Reuters, the White House spokesman stressed, however, that the resignation was not an ultimatum, but rather an incentive to pressure “the FDA to act quickly and complete the job without delay.”
“Pass the damn vaccine,” says Donald Trump
In a previous tweet, outgoing US President Donald Trump also lobbied the FDA to speed up the vaccine approval process. “Although my funding has saved the FDA bureaucratic five years in approving a SERIES of important new vaccines, it’s still a big, old, slow turtle. Get the damn vaccine now, Dr. Han. Stop playing around and start saving lives !! “He wrote.
First vaccinations even within 36 hours of vaccine approval
“The first shipment of vaccines will be made the day after the vaccine is approved. […] “It will take around 24 hours to get to the various points that we were told by the officials in the United States, and within 36 hours of approval, the first vaccine could possibly take place,” he told the Boston Herald. from Operation Warp Speed.
Operation Warp Speed is a public-private partnership initiated by the US government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapies, and diagnostics.
Operation Warp Speed plans to vaccinate 20,000,000 people by the end of the year. “There are no serious side effects associated with these vaccines,” Slaoui said.
The contribution of the vaccine against Covid-19 disease
According to an FDA analysis during the week, the vaccine appears to offer the benefits for which it was created, that is, to help reduce the risk of developing Covid-19 disease, at least 7 days after the second dose.
Another positive element is that the vaccine seems to give results even after the first dose, in the interval between this and the second dose that is destined for its full action in the human body.
82% effective from the first dose
More specifically, the vaccine could be up to 82% effective against Covid disease after the first dose. In any case, the FDA notes that there is insufficient data to reach a solid conclusion on this.
On the issue of security, which is of particular concern to experts and citizens, the investigation states that “no specific security concerns were identified, which would hamper urgent licensing.” In particular, serious side effects have rarely been reported. After all, the registration of such cases is common in such investigations.
[ad_2]
